OncoTricks

Chest syndrome, growth factor, a million platelets and iron, Oct 7, 2026

Sickle cell pain crisis: watch the chest

If you remember one thingChest syndrome is usually made on the ward around day 3 of a pain admission. Ten breaths on the spirometer every 2 hours awake, fluids at maintenance, look at the chest every day.

Every day of a pain admission

Spirometer: 10 breaths every 2 hours awake+Fluids: no more than maintenance+Pain controlled, patient awake
No spirometerSpirometer
Pain admissions in 29 patients aged 8 to 21 (38 episodes) that developed a lung complication, out of 19 in each group
No spirometer
8 of 19
Spirometer
1 of 19

The chest film got worse

New infiltrate filling a lung segment, plus fever or any respiratory sign?Chest pain, cough, fast breathing, wheeze, low oxygen. Fever is less reliable in adults.
no
Not chest syndrome yetCheck fluid balance, weight and sedation. Film again if saturation is 94% or less, or falls 3%.
yes
Acute chest syndromeIV cephalosporin + oral macrolide. Oxygen to keep saturation above 95%. Spirometer.
then
Hemoglobin more than 1 g/dL below baseline?
yes
Simple transfusionNot above a hemoglobin of 10. Tell the blood bank the patient has sickle cell disease.
and
Saturation under 90% on oxygen, or getting worse?If transfusion is needed and the hemoglobin is already 9 or higher, exchange instead of top-up: a top-up would push past 10.
yes
Exchange transfusionCall hematology, apheresis and the ICU

Definitions differ. The guidelines ask for the infiltrate plus one sign. The National Acute Chest Syndrome Study Group used a new infiltrate plus at least one of chest pain, fever above 38.5 C, fast breathing, wheeze or cough, or low oxygen.

Two things arrive around day 3

Day 1 2 3 4 5 Acute chest syndrome Fluid overload from IV fluids

They can look alike on the film. Before the label, weigh the patient, add up the balance, look at the legs. On the Dutch protocol of 3 liters a day, 21 of 100 patients became overloaded (18% of adults). A top-up transfusion during the admission raised the odds six-fold.

The numbers
  • 671 episodes: 13% needed a ventilator, 3% died. Adults do worse than children.
  • Per 100 patient-years: SS 12.8, S-beta-zero 9.4, SC 5.2, S-beta-plus 3.9. Prevention and antibiotics are the same for every genotype. Transfusion is not: in SC and S-beta-plus the baseline hemoglobin is higher, so call hematology before any top-up.
  • Steroids: not routinely. They shorten the episode and bring the patient back with pain.
  • Hydroxyurea takes months to work, so it does not treat this episode. It prevents the next one: chest syndrome in 25 vs 51 patients.
  • New, not yet in guidelines: in a 2025 randomized trial of 172 adults with no clot on CT angiogram, therapeutic-dose tinzaparin for 7 days resolved the episode faster than prophylactic-dose tinzaparin (hazard ratio 0.71, confidence interval just under 1.0; about 4.8 vs 6.1 days), with no major bleeding in either arm and less opioid use.
Sources

Retrieved from PubMed, read on Oct 15, 2026. The NHLBI 2014 report, the British 2015 guideline, the ASH 2020 transfusion guideline, the 2025 anticoagulation trial and the fluid overload study were read in full text. The 1995 and 2000 trials were read as abstracts.

  1. Vichinsky EP, et al. Causes and outcomes of the acute chest syndrome. N Engl J Med 2000. doi:10.1056/NEJM200006223422502
  2. Bellet PS, et al. Incentive spirometry to prevent acute pulmonary complications. N Engl J Med 1995. doi:10.1056/NEJM199509143331104
  3. NHLBI. Evidence-based management of sickle cell disease, expert panel report 2014. Report. Summary: Yawn BP, et al. JAMA 2014. doi:10.1001/jama.2014.10517
  4. Howard J, et al. British guideline on acute chest syndrome in sickle cell disease. Br J Haematol 2015. doi:10.1111/bjh.13348
  5. Chou ST, et al. ASH 2020 guidelines for sickle cell disease: transfusion support. Blood Adv 2020. doi:10.1182/bloodadvances.2019001143
  6. Gaartman AE, et al. Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis. Br J Haematol 2021. doi:10.1111/bjh.17696
  7. Castro O, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. Blood 1994;84:643. PMID 7517723
  8. Strouse JJ, et al. Corticosteroids and readmission after acute chest syndrome. Pediatr Blood Cancer 2008. doi:10.1002/pbc.21336
  9. Mekontso Dessap A, et al. TASC: prophylactic vs therapeutic anticoagulation in acute chest syndrome. Am J Respir Crit Care Med 2025. doi:10.1164/rccm.202409-1727OC
  10. Creary SE, Strouse JJ. Hydroxyurea and transfusion therapy for sickle cell disease, ASH pocket guide adapted from the NHLBI 2014 report. Guide
  11. Charache S, et al. Hydroxyurea in sickle cell anemia. N Engl J Med 1995. doi:10.1056/NEJM199505183322001